GleamWall
中文EN

SYRA Syra Health Corp

Services-Employment Agencies · OTC · SEC CIK 1922335 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY19.5%
TTM net income YoY155.4%
TTM EPS YoY150.0%
Revenue 3-yr CAGR16.2%
Net income 3-yr CAGR—

Margins

Gross margin42.6%
Operating margin6.8%
Net margin7.8%
FCF margin—
EBITDA margin6.8%

Returns

ROE26.8%
ROA18.7%
ROIC (approx.)109.8%
Asset turnover2.39x

Leverage & solvency

Liabilities / assets28.4%
Debt / equity0.00x
Current ratio3.47x
Interest coverage58.86x

Cash quality & payout

Operating cash flow / net income0.98x
Accruals ratio0.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$7.23M$7.98M
Cost of revenue$4.74M$6.33M
Gross profit$2.49M$1.65M
R&D expense$67,840$585,146
SG&A expense$1.07M$1.45M
Operating income-$904,324-$3.76M
Interest expense$13,270$15,600
Net income-$896,333-$3.76M
EBITDA-$883,856-$3.70M
EPS (basic)-0.08-0.50
EPS (diluted)-0.08-0.50
Weighted avg. shares (diluted)11.85M7.55M
Balance sheet
Cash & equivalents$1.61M$2.40M
Receivables$918,374$680,827
Current assets$2.74M$3.35M
PP&E, net$6,986$27,347
Total assets$2.77M$3.68M
Current liabilities$674,739$613,549
Total liabilities$674,739$800,761
Shareholders' equity$2.10M$2.88M
Cash flow statement
Operating cash flow-$447,746-$2.93M
Capital expenditure$107$11,111
Free cash flow-$447,853-$2.94M
Investing cash flow-$107-$11,111
Financing cash flow-$332,819$2.06M
Depreciation & amortization$20,468$62,738
Stock-based compensation$98,554$59,803

Free plan shows the latest 2 periods; Pro shows all 4 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.